Skip to main content
Premium Trial:

Request an Annual Quote

Link Technologies Inks North American Distribution Deal with AIC

NEW YORK (GenomeWeb News) – Link Technologies today announced a deal with American International Chemical for the distribution of some Link products in North America.

Under the terms of the deal, AIC will distribute a subset of the Bellshill, Scotland firm's oligonucleotide reagents. The deal focuses on the bulk market for oligonucleotide modifiers and will initially begin with the distribution of Link's modified phosphoramidites, including dyes and labels and CPG solid supports. The products will be distributed through AIC's Advanced Technology Division.

Link said it will remain in direct contact with existing and new customers in North America at the customers' discretion and will continue providing technical support to its North American customers.

Financial and other terms of the deal were not disclosed.

Link is a kilo-scale supplier of specialty reagents for oligonucleotide synthesis and modification. AIC's Advanced Technology Division is based in Framingham, Mass., and provides specialty chemicals and biotech chemicals.

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.